Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Sitz-Markers are radiopaque markers used as a diagnostic tool to evaluate gastrointestinal motility and colonic transit time. They are particularly utilized in clinical settings to assess the return of bowel function following colorectal surgery or to diagnose conditions like chronic constipation and colonic inertia. The markers, typically contained within a gelatin capsule, are swallowed by the patient, and their progression through the digestive tract is monitored using serial abdominal X-rays. By visualizing the distribution and retention of these markers in the colon, clinicians can objectively determine the speed and efficiency of bowel movements. While often regulated as a medical device, they are classified as a drug intervention in some clinical trial registries due to their oral administration and investigational use in measuring physiological recovery.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Sitz-Markers.